John Wahren
Director Técnico/Científico/I+D en Creative Peptides Sweden AB .
Cargos activos de John Wahren
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Creative Peptides Sweden AB
 Creative Peptides Sweden AB Pharmaceuticals: MajorHealth Technology Creative Peptides Sweden AB develops and manufactures drugs. The company discovers and develops biopharmaceutical drugs to treat complications of Type 1 diabetes. It was founded in 1996 and is headquartered in Stockholm, Sweden. | Director Técnico/Científico/I+D | - | - |
| Karolinska Institutet | Corporate Officer/Principal | 24/06/2009 | - |
Historial de carrera de John Wahren
Antiguos cargos conocidos de John Wahren.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| University of Lausanne | Corporate Officer/Principal | 01/01/1984 | 01/01/1984 |
Cebix, Inc.
 Cebix, Inc. Pharmaceuticals: MajorHealth Technology Cebix, Inc. provided treatments for complications of diabetes. It developed Ersatta, a proprietary disease-modifying replacement peptide for the treatment of complications associated with diabetes, including diabetic peripheral neuropathy, autonomic neuropathy, nephropathy, and retinopathy. The company was founded by John Wahren and Lars G. Ekman in 2008 and was headquartered in San Diego, CA. | Director/Miembro de la Junta | 24/06/2009 | - |
| Director Técnico/Científico/I+D | 24/06/2009 | - | |
| Fundador | 13/04/2010 | - |
Formación de John Wahren.
| Karolinska Institutet | Doctorate Degree |
Estadísticas
Internacional
| Suecia | 3 |
| Estados Unidos | 2 |
| Suiza | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Cebix, Inc.
Cebix, Inc. Pharmaceuticals: MajorHealth Technology Cebix, Inc. provided treatments for complications of diabetes. It developed Ersatta, a proprietary disease-modifying replacement peptide for the treatment of complications associated with diabetes, including diabetic peripheral neuropathy, autonomic neuropathy, nephropathy, and retinopathy. The company was founded by John Wahren and Lars G. Ekman in 2008 and was headquartered in San Diego, CA. | Health Technology |
Creative Peptides Sweden AB
Creative Peptides Sweden AB Pharmaceuticals: MajorHealth Technology Creative Peptides Sweden AB develops and manufactures drugs. The company discovers and develops biopharmaceutical drugs to treat complications of Type 1 diabetes. It was founded in 1996 and is headquartered in Stockholm, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- John Wahren
- Experiencia
